Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/31/16 → 5/30/18 |
Funding
- United Biosource Corp: $21,138.00
Randomized, Double-Blind, Phase 3 Study Evaluating TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC In Patients With Metastatic Gastric Cancer Refractory to Standard Treatments
- Mathew, Aju (PI)
- Anthony, Lowell (CoI)
- Myers, Adria (CoI)
- Goel, Gaurav (Former PI)
- Hosein, Peter (Former CoI)